摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-N-[4-(4-氯苯氧基)苯基]乙酰胺 | 36160-92-6

中文名称
2-氯-N-[4-(4-氯苯氧基)苯基]乙酰胺
中文别名
——
英文名称
2-chloro-N-(4-(4-chlorophenoxy)phenyl)acetamide
英文别名
2-chloro-N-[4-(4-chlorophenoxy)phenyl]acetamide
2-氯-N-[4-(4-氯苯氧基)苯基]乙酰胺化学式
CAS
36160-92-6
化学式
C14H11Cl2NO2
mdl
MFCD00437789
分子量
296.153
InChiKey
LQBGPTCOVFQOIC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:ec6d0c3ef20aa4dca2dcfc4478ecbc75
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1H-1,2,4-三唑2-氯-N-[4-(4-氯苯氧基)苯基]乙酰胺 在 potassium hydroxide 作用下, 以 乙腈 为溶剂, 反应 9.5h, 以88%的产率得到N-[4-(4-chlorophenoxy)phenyl]-2-(1H-1,2,4-triazol-1-yl)acetamide
    参考文献:
    名称:
    Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation
    摘要:
    3-Nitro-1H-1,2,4-triazole-and 2-nitro-1H-imidazole-based amides with an aryloxy-phenyl core were synthesized and evaluated as antitrypanosomal agents. All 3-nitrotriazole-based derivatives were extremely potent anti-Trypanosoma cruzi agents at sub nM concentrations and exhibited a high degree of selectivity for the parasite. The 2-nitroimidazole analogs were only moderately active against T. cruzi amastigotes and exhibited low selectivity. Both types of compound were active against Leishmania donovani axenic amastigotes with excellent selectivity for the parasite, whereas three 2-nitroimidazole-based analogs were also moderately active against infected macrophages. However, no compound demonstrated selective activity against Trypanosoma brucei rhodesiense. The most potent in vitro anti-T. cruzi compounds were tested in an acute murine model and reduced the parasites to an undetectable level after five days of treatment at 13 mg/kg/day. Such compounds are potential inhibitors of T. cruzi CYP51 and, being excellent substrates for the type I nitroreductase (NTR) which is specific to trypanosomatids, work as prodrugs and constitute a new generation of effective and more affordable antitrypanosomal agents. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2015.08.014
  • 作为产物:
    描述:
    参考文献:
    名称:
    含有(ω-对-溴苯氧基烷基)尿嘧啶部分的新乙酰胺衍生物及其抗巨细胞病毒活性
    摘要:
    从1- [ω- (4-溴苯氧基)烷基]尿嘧啶和2-氯-N-(4-苯氧基苯基)乙酰胺衍生物。他们对人类巨细胞病毒的抗病毒特性的调查表明,具有十二烷-1,12-二基接头的代表在体外表现出强大的病毒抑制活性。
    DOI:
    10.1016/j.mencom.2020.09.016
点击查看最新优质反应信息

文献信息

  • METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20190290778A1
    公开(公告)日:2019-09-26
    Provided herein, inter alia, are methods and compounds for targeted autophagy.
    本文提供了针对靶向自噬的方法和化合物。
  • Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
    作者:Charles A. Berdan、Raymond Ho、Haley S. Lehtola、Milton To、Xirui Hu、Tucker R. Huffman、Yana Petri、Chad R. Altobelli、Sasha G. Demeulenaere、James A. Olzmann、Thomas J. Maimone、Daniel K. Nomura
    DOI:10.1016/j.chembiol.2019.03.016
    日期:2019.7
    parthenolide in human breast cancer cells. We find that parthenolide, as well as other related exocyclic methylene lactone-containing sesquiterpenes, covalently modify cysteine 427 of focal adhesion kinase 1 (FAK1), leading to impairment of FAK1-dependent signaling pathways and breast cancer cell proliferation, survival, and motility. These studies reveal a functional target exploited by members of a
    白菊内酯是小白菊植物的天然产物,是倍半萜内酯大家族的成员,具有多种生物和治疗活性,包括抗炎和抗癌作用。在这里,我们进一步研究基于基于活性蛋白谱的化学旋转平台的单性作用机理,以绘制由单性参与人乳腺癌细胞中的其他共价靶标的图谱。我们发现,单苯乙内酯,以及其他相关的含环亚甲基内酯倍半萜烯,共价修饰粘着斑激酶1(FAK1)的半胱酸427,导致FAK1依赖的信号通路和乳腺癌细胞的增殖,存活和运动性受损。这些研究揭示了一大类抗癌天然产物成员利用的功能靶标。
  • New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties
    作者:Dmitry O. Koltun、Timothy A. Marquart、Kevin D. Shenk、Elfatih Elzein、Yuan Li、Marie Nguyen、Suresh Kerwar、Dewan Zeng、Nancy Chu、Daniel Soohoo、Jia Hao、Victoria Y. Maydanik、David A. Lustig、Khing-Jow Ng、Heather Fraser、Jeffery A. Zablocki
    DOI:10.1016/j.bmcl.2003.09.093
    日期:2004.1
    New inhibitors of palmitoylCoA oxidation were synthesized based on a structurally novel lead, CVT-3501 (1). Investigation of structure-activity relationships was conducted with respect to potency of inhibition of cardiac mitochondrial palmitoylCoA oxidation and metabolic stability. Potent and metabolically stable analogues 33, 42, and 43 were evaluated in vitro for cytochrome P450 inhibition and potentially adverse electrophysiological effects. Compound 33 was also found to have favorable pharmacokinetic properties in rat. (C) 2003 Elsevier Ltd. All rights reserved.
  • Preparations of ω-Aminosubstituted-acetamidodiphenyl Ether Perivatives and Their Pharmacological Actions
    作者:YOSHIKI HAMADA、MICHIHARU SUGIURA、TAKASHI NISHINA、KAZUNORI ARAKI、KAZUTOSHI HORIGOME、ZENICHI HENMI
    DOI:10.1248/yakushi1947.98.12_1597
    日期:——
  • HAMADA YOSHIKI; SUGIURA MICHIHARU; NISHINA TAKASHI; KAWAZURA HIROSHI; SAI+, YAKUGAKU DZASSI, YAKUGAKU ZASSNI, J. PHARM. SOS. JAR., 1980, 100, NO 5, 5+
    作者:HAMADA YOSHIKI、 SUGIURA MICHIHARU、 NISHINA TAKASHI、 KAWAZURA HIROSHI、 SAI+
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫